Hepatology

Lifestyle interventions, particularly achieving a weight loss of over 10%, have been shown to resolve MASH.

A 96-week study finds bulevirtide safe and effective for HDV-related cirrhosis, improving liver health and reducing complications.

Low donor fasting glucose predicts poorer outcomes after LDLT, highlighting its potential as a prognostic marker.

A Mediterranean diet, rich in whole grains, vegetables, fruits, nuts, and olive oil, is proven to improve liver health by reducing inflammation and fat accumulation.

The tool’s performance was consistent across multiple validation cohorts, though accuracy varied slightly, especially when dealing with different patient populations.

The study’s findings demonstrate that hypovolaemic phlebotomy effectively reduces the need for red blood cell transfusions.

Obesity and diabetes mellitus are widely acknowledged risk factors for the development of steatotic liver diseases, contributing to liver cirrhosis and HCC.

Cirrhosis-associated immune dysfunction heightens infection susceptibility through low-grade systemic inflammation and gut-liver axis alterations.